The gastric precancerous cascade
暂无分享,去创建一个
[1] M. Borodovsky,et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[2] Alter Mj,et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.
[3] N. Yoshimura,et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels , 2009, International journal of cancer.
[4] B. Nielsen,et al. Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high‐ and low‐risk countries , 2010, International journal of cancer.
[5] K. Miki. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method” , 2011, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[6] L. Bravo,et al. Eosinophils and mast cells in chronic gastritis: possible implications in carcinogenesis. , 2008, Human pathology.
[7] E. Fontham,et al. Age at Acquisition of Helicobacter pylori Infection: Comparison of Two Areas with Contrasting Risk of Gastric Cancer , 2004, Helicobacter.
[8] M. Blaser,et al. Helicobacter pylori in health and disease. , 2009, Gastroenterology.
[9] S. Czinn,et al. Helicobacter-associated gastritis in SCID mice , 1995, Infection and immunity.
[10] P. Correa,et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. , 1976, Journal of the National Cancer Institute.
[11] M. Gail,et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.
[12] A. Gobert,et al. BASIC AND TRANSLATIONAL — ALIMENTARY TRACT Spermine Oxidase Mediates the Gastric Cancer Risk Associated With Helicobacter pylori CagA , 2011 .
[13] B. Morson. Carcinoma Arising from Areas of Intestinal Metaplasia in the Gastric Mucosa , 1955, British Journal of Cancer.
[14] R. Peek,et al. Helicobacter pylori in gastric carcinogenesis: mechanisms. , 2013, Gastroenterology clinics of North America.
[15] M. Plummer,et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.
[16] S. Tominaga,et al. A Prospective Study of Atrophic Gastritis and Stomach Cancer Risk , 1992, Japanese journal of cancer research : Gann.
[17] E. Kuipers,et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. , 2010, Gastrointestinal endoscopy.
[18] M. Blaser,et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.
[19] L. Janzon,et al. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. , 1994, Scandinavian journal of gastroenterology.
[20] T. Blanchard,et al. Immunological determinants that may affect the Heliobacter pylori cancer risk , 1998 .
[21] T. Graham,et al. The clonal origins of dysplasia from intestinal metaplasia in the human stomach. , 2011, Gastroenterology.
[22] M. Ghigna,et al. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. , 2006, Human pathology.
[23] J. Gisbert,et al. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence , 2013, International journal of cancer.
[24] G. Friedman,et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. , 1997, Gut.
[25] D. Graham,et al. Eradication of gastric cancer is now both possible and practical. , 2013, Seminars in cancer biology.
[26] P. Correa. The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. , 1980, Frontiers of gastrointestinal research.
[27] T. Shimosegawa,et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. , 2009, World journal of gastroenterology.
[28] M. Achtman,et al. Recombination and clonal groupings within Helicobacter pylori from different geographical regions , 2012 .
[29] E. Fontham,et al. Gastric precancerous process in a high risk population: cross-sectional studies. , 1990, Cancer research.
[30] P. Correa,et al. The transmission of Helicobacter pylori. A critical review of the evidence. , 1995, International journal of epidemiology.
[31] Laura C. Greaves,et al. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. , 2008, Gastroenterology.
[32] J. Goldenring,et al. Current understanding of SPEM and its standing in the preneoplastic process , 2009, Gastric Cancer.
[33] N. Muñoz,et al. Age and Severity of Mucosal Lesions Influence the Performance of Serologic Markers in Helicobacter pylori–Associated Gastroduodenal Pathologies , 2008, Cancer Epidemiology Biomarkers & Prevention.
[34] P. Correa,et al. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. , 1970, Journal of the National Cancer Institute.
[35] J. Posthuma,et al. Morphology of the Stomach and Gastric Secretion in Malays and Chinese and the Different Incidence of Gastric Ulcer and Cancer in These Races , 1938 .
[36] L. Bravo,et al. Virulence-associated genotypes of helicobacter pylori: do they explain the african enigma? , 2002, American Journal of Gastroenterology.
[37] F. Bosman,et al. WHO Classification of Tumours of the Digestive System , 2010 .
[38] G. Capellá,et al. Gastric cancer occurrence in preneoplastic lesions: A long‐term follow‐up in a high‐risk area in Spain , 2010, International journal of cancer.
[39] J. Mills,et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach. , 2010, Gastroenterology.
[40] P. Sipponen,et al. INTESTINAL METAPLASIA WITH COLONIC‐TYPE SULPHOMUCINS IN THE GASTRIC MUCOSA; ITS ASSOCIATION WITH GASTRIC CARCINOMA , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[41] L. Bravo,et al. Analysis of cagA in Helicobacter pylori Strains from Colombian Populations with Contrasting Gastric Cancer Risk Reveals a Biomarker for Disease Severity , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[42] E. Kuipers,et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. , 2008, Gastroenterology.
[43] D. Graham,et al. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. , 1996, Gastroenterology.
[44] P. Malfertheiner,et al. OLGA staging for gastritis: a tutorial. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[45] E. Fontham,et al. Diet and chronic atrophic gastritis: a case-control study. , 1986, Journal of the National Cancer Institute.
[46] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[47] G. Stemmermann,et al. Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. , 1968, Journal of the National Cancer Institute.
[48] T G Blanchard,et al. Review article: Immunological determinants that may affect the Helicobacter pylori cancer risk. , 1998, Alimentary pharmacology & therapeutics.
[49] R. Rappuoli,et al. Helicobacter pylori virulence and genetic geography. , 1999, Science.
[50] F. Chan,et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication , 2004, Gut.
[51] P. Barbini,et al. Gastric intestinal metaplasia type III cases are classified as low‐grade dysplasia on the basis of morphometry , 1993, The Journal of pathology.
[52] P. Malfertheiner,et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2012, Endoscopy.
[53] K. Miki. Gastric cancer screening using the serum pepsinogen test method , 2002, Gastric Cancer.
[54] J. DeLany,et al. Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. , 1996, American journal of epidemiology.
[55] L. Bravo,et al. Intestinal Helminthiasis in Colombian Children Promotes a Th2 Response to Helicobacter pylori: Possible Implications for Gastric Carcinogenesis , 2005, Cancer Epidemiology Biomarkers & Prevention.
[56] M. Blaser,et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.
[57] L. Bravo,et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk , 2011, Gut.
[58] P. Correa,et al. Sulphomucins favour adhesion of Helicobacter pylori to metaplastic gastric mucosa. , 1999, Journal of clinical pathology.
[59] Ming-Shiang Wu,et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. , 2009, Gastroenterology.
[60] M. Piazuelo,et al. Pathology of Gastric Intestinal Metaplasia: Clinical Implications , 2010, The American Journal of Gastroenterology.
[61] Khean Lee Goh,et al. Screening for gastric cancer in Asia: current evidence and practice. , 2008, The Lancet. Oncology.
[62] T. Rokkas,et al. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. , 1991, Gut.
[63] E. Fontham,et al. Long term follow up of patients treated for Helicobacter pylori infection , 2005, Gut.
[64] M. Blaser,et al. Role of Helicobacter pylori cagA+ strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia , 1999, International journal of cancer.
[65] P. Laurén,et al. On the role of heterotopias of the intestinal epithelium in the pathogenesis of gastric cancer. , 2009, Acta pathologica et microbiologica Scandinavica.
[66] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[67] N. Muñoz,et al. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia , 1994, International journal of cancer.
[68] E. Kuipers,et al. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. , 2009, Gastrointestinal endoscopy.
[69] M F Dixon,et al. The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.
[70] M. Sobrinho-Simões,et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. , 1999, Cancer research.
[71] T. Hirota,et al. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. , 1980, Journal of the National Cancer Institute.
[72] M. Rugge,et al. Gastric dysplasia: the Padova international classification. , 2000, The American journal of surgical pathology.
[73] M. Filipe,et al. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material. , 1986, Human pathology.
[74] B. Marshall,et al. UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.
[75] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[76] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.
[77] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[78] Keith T. Wilson,et al. Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.
[79] M. Gail,et al. Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2001, Journal of the National Cancer Institute.
[80] R. P. Blankfield,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[81] D. Graham,et al. Topographic patterns of intestinal metaplasia and gastric cancer , 2000, American Journal of Gastroenterology.
[82] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[83] H. Watanabe,et al. Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists. , 1999, The American journal of surgical pathology.
[84] D. McGee,et al. Gastric intestinal metaplasia in ethnic groups in the southwestern United States. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[85] M. Rugge,et al. Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. , 2011, Human pathology.
[86] N. Yoshimura,et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer , 2004, International journal of cancer.
[87] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.
[88] P. Malfertheiner,et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2012, Endoscopy.
[89] R. Rappuoli,et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[90] D. Parkin,et al. The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.
[91] P. Correa,et al. A human model of gastric carcinogenesis. , 1988, Cancer research.
[92] E. Kuipers,et al. Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn? , 2009, The American Journal of Gastroenterology.
[93] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[94] J. Fraumeni,et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. , 1992, Journal of the National Cancer Institute.
[95] Ali Ms. Letter: Geriatrics is medicine. , 1974, Lancet.
[96] A. Lilienfeld,et al. MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1976, The Lancet.
[97] E. Kuipers,et al. Precancerous lesions in the stomach: from biology to clinical patient management. , 2013, Best practice & research. Clinical gastroenterology.
[98] G. Capellá,et al. Helicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain , 2011, The American Journal of Gastroenterology.
[99] P. Correa,et al. Morbidity and mortality from cancer in Cali, Colombia. , 1966, Journal of the National Cancer Institute.
[100] J. Noto,et al. The Helicobacter pylori cag Pathogenicity Island. , 2012, Methods in molecular biology.
[101] B. C. Wong,et al. Gastric cancer chemoprevention: the current evidence. , 2013, Gastroenterology clinics of North America.
[102] E. Fontham,et al. Gastric precancerous process in a high risk population: cohort follow-up. , 1990, Cancer research.
[103] K. Chayama,et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis , 2002, Alimentary pharmacology & therapeutics.
[104] J. Rotter,et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. , 1982, Gastroenterology.